This site is intended for healthcare professionals
  • Home
  • /
  • Guidelines
  • /
  • Gout
  • /
  • The British Society for Rheumatology Guideline for...

The British Society for Rheumatology Guideline for the Management of Gout

Read time: 1 mins
Last updated:1st Jul 2017

Gout is the most common cause of inflammatory arthritis worldwide. In UK general practice, the overall prevalence has increased from 1.4% in 1999 to 2.49% in 2012 [1], despite the availability of effective and potentially curative urate-lowering drugs for >50 years and evidence-based British and European management guidelines for nearly a decade [2, 3].

This guideline aims to offer revised and updated, concise, patient-focused, evidence-based, expert recommendations for the management of gout in the UK.


Read full guideline